| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |